Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Moleculin Biotech, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 26 | 23 | −3 |
| Shares | 3.02M | 2.96M | −64.2K (−2.1%) |
| Value | $5.61M | $5.26M | −$353.0K (−6.3%) |
New holders (4)
Institutions that held Moleculin Biotech, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Envestnet Asset Management Inc | 10,404 | $19.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,191 | $7.00K | 0.00% |
| JPMorgan Chase & Co | 594 | $1.00K | 0.00% |
| Global Retirement Partners, LLC | 168 | $0 | 0.00% |
Sold out (7)
Institutions that held Moleculin Biotech, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Virtu Financial LLC | 46,647 | $87.0K |
| Two Sigma Securities, LLC | 22,174 | $41.0K |
| Occudo Quantitative Strategies LP | 22,013 | $41.0K |
| Susquehanna Fundamental Investments, LLC | 19,883 | $37.0K |
| Goldman Sachs Group Inc | 11,825 | $22.0K |
| Migdal Insurance & Financial Holdings Ltd. | 1,425 | $2.00K |
| Prestige Wealth Management Group LLC | 167 | $0 |